Drug Type Small molecule drug |
Synonyms 5-ALA/SFC, Aminolevulinic acid/sodium ferrous citrate, Sodium ferrous citrate/aminolevulinic acid + [2] |
Target- |
Action stimulants |
Mechanism Erythropoiesis stimulants(Erythropoiesis stimulants), Photosensitizers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC6H8FeNaO7 |
InChIKeyRRLYRAWRPAFIMT-UHFFFAOYSA-N |
CAS Registry43160-25-4 |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| COVID-19 | Clinical | India | 15 Mar 2022 | |
| Diabetes Mellitus, Type 2 | Clinical | - | 01 Jul 2014 | |
| Chronic Kidney Diseases | Preclinical | Japan | 01 Mar 2025 | |
| Chronic Kidney Diseases | Preclinical | Japan | 01 Mar 2025 | |
| Chronic Kidney Diseases | Preclinical | Japan | 01 Mar 2025 |





